.
BIOC financial statements
* Numbers in thousands
Year |
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Capitalization * |
20 | 37 | 8 433 | 23 485 | 14 080 | 9 264 | 5 261 | 6 405 | 69 532 | 23 809 |
EV * |
22 211 | 7 149 | 7 879 | 19 001 | 12 791 | 8 695 | 2 479 | -1 330 | 65 933 | 65 933 |
Stock price $ |
7.21 | 7.28 | 1899 | 1278 | 441 | 102 | 18.8 | 3.1 | 5.87 | 2.01 |
Number of shares * |
3 | 5 | 4 | 18 | 32 | 91 | 280 | 2 066 | 11 845 | 11 845 |
EPS |
-4 419,44 | -1 837,82 | -3 572,63 | -922,37 | -576,29 | -237,98 | -87,81 | -12,17 | -1,50 | -1,50 |
Revenue * |
109 | 134 | 133 | 610 | 3 223 | 5 069 | 3 250 | 5 529 | 27 461 | 27 461 |
Net income * |
-12 260 | -9 233 | -15 866 | -16 950 | -18 399 | -21 614 | -24 572 | -25 138 | -17 807 | -17 807 |
Operating profit * |
-10 503 | -7 944 | -13 874 | -16 411 | -18 025 | -21 175 | -24 259 | -23 057 | -15 468 | -15 468 |
Total liabilities * |
28 855 | 13 786 | 6 809 | 6 894 | 6 920 | 6 083 | 5 708 | 6 532 | 23 759 | 23 759 |
Net debt * |
22 191 | 7 112 | -554 | -4 484 | -1 289 | 581 | -1 797 | -6 761 | -3 599 | -3 599 |
Total assets * |
1 470 | 1 330 | 6 588 | 10 587 | 7 578 | 7 379 | 8 750 | 17 733 | 47 452 | 47 452 |
Equity * |
-27 385 | -12 456 | -221 | 3 693 | 659 | 1 296 | 3 043 | 11 201 | 23 692 | 23 692 |
Cash and investments * |
185 | 69 | 5 365 | 8 821 | 4 609 | 2 147 | 3 423 | 9 301 | 14 368 | 14 368 |
Over the past 10 years, the maximum capitalization of Biocept, Inc. is 69 532, the minimum is 20. Maximum net income 0, Minimum net income -25 138. The maximum price of BIOC shares is 1899, the minimum price is 3.1.
.
BIOC valuation
Year |
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
0,00 | 0,00 | -0,53 | -1,39 | -0,77 | -0,43 | -0,21 | -0,25 | -3,90 | -1,34 |
P/B |
0,00 | 0,00 | -38,24 | 6,36 | 21,38 | 7,15 | 1,73 | 0,57 | 2,93 | 1,00 |
P/S |
0,18 | 0,27 | 63,21 | 38,51 | 4,37 | 1,83 | 1,62 | 1,16 | 2,53 | 0,87 |
E/P |
-61 296% | -25 245% | -188% | -72% | -131% | -233% | -467% | -392% | -26% | -75% |
P/FCF |
0,00 | -0,01 | -0,56 | -1,53 | -0,87 | -0,44 | -0,23 | -0,27 | -3,37 | -1,15 |
.
BIOC profitability
Year |
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
ROE |
45% | 74% | 7 193% | -459% | -2 793% | -1 668% | -808% | -224% | -75% | |
ROA |
-834% | -694% | -241% | -160% | -243% | -293% | -281% | -142% | -38% | |
ROIC |
40% | 66% | -269% | -226% | -566% | -779% | -586% | -189% | -44% |